Skip to main content

Table 5 Relation between overall survival and clinicopathological variables

From: Prognostic value of S100A4 and Glypican-3 in hepatocellular carcinoma in cirrhotic HCV patients

 

Median overall survival (95% CI)

Log rank (Mantel-Cox)

p-value

Sex

 Male

6 (2–9.9)

0.276

0.600

 Female

3 (0–21)

S100

 Positive

9 (1.7–16.2)

0.585

0.444

 Negative

6 (1.9–10.05)

Glypican

 Positive

5 (0–10.6)

1.327

0.249

 Negative

8 (3.3–12.6)

Decompensation

 Yes

2 (0.2–3.7)

3.79

0.012*

 No

9 (7.5–10.5)

Recurrence

 Yes

6 (0–15.4)

0.381

0.537

 No

8 (3.8–12.15)

Metastasis

 Yes

3 (0–6.6)

0.165

0.684

 No

8 (4.4–11.5)

Necrosis

 Yes

4 (1.5–6.4)

1.835

0.176

 No

9 (5.3–12.7)

Microscopic vascular emboli

 Yes

9 (1.6–16.4)

0.037

0.848

 No

6 (2.02–9.9)

Grading

 1

10 (2.7–17.3)

6.164

0.046*

 2

3 (0.6–5.35)

 3

5 (0–12.5)

  1. *p value >0.05% and is statistically significant